Pangea Biomed Israeli Company
Pangea Biomed is the developer of ENLIGHT, an advanced pan-cancer, pan-therapy response predictor. By combining machine learning, artificial intelligence, and deep RNA analysis, the company is mapping tumor molecular signatures to dynamically and adaptively personalize cancer care. Pangea's unsupervised machine-learning approach makes ENLIGHT scalable and effective during the drug development process, when no clinical data is yet available.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical
Oncology
Alternatives
No alternatives listed yet.
Suggest an Alternative
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/pangea-biomed
[2]
crunchbase.com
- https://www.crunchbase.com/organization/pangea-biomed
External links are provided for reference and verification purposes.